Evidence map›Paper›PMID 27228556›Full record

ArticlePLoS biology2016

Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling.

Oihane Abiega, Sol Beccari, Irune Diaz-Aparicio, Agnes Nadjar, Sophie Layé, Quentin Leyrolle, Diego Gómez-Nicola, María Domercq, Alberto Pérez-Samartín, Víctor Sánchez-Zafra and 16 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 120 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed, 1 pooled it
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 1 synthesis or guideline pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Glial cells in neuropathic pain.Physiological reviews · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Upregulation of adenosine AMolecular psychiatry · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 5 countries.

Oihane AbiegaAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.ORCID 0000-0002-5428-7823
Sol BeccariAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.ORCID 0000-0003-3959-462X
Irune Diaz-AparicioAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.ORCID 0000-0003-0048-9005
Agnes NadjarUniversité Bordeaux Segalen, Bordeaux, France.
Sophie LayéUniversité Bordeaux Segalen, Bordeaux, France.
Quentin LeyrolleUniversité Bordeaux Segalen, Bordeaux, France.
Diego Gómez-NicolaCentre for Biological Sciences, University of Southampton, Southampton, United Kingdom.
María DomercqAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.
Alberto Pérez-SamartínAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.
Víctor Sánchez-ZafraAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.
Iñaki ParisAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.ORCID 0000-0002-3887-0277
Jorge ValeroAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.ORCID 0000-0001-6072-3313
Julie C SavageCentre de recherche du CHU de Québec, Axe Neurosciences, Québec, Canada.
Chin-Wai HuiCentre de recherche du CHU de Québec, Axe Neurosciences, Québec, Canada.
Marie-Ève TremblayCentre de recherche du CHU de Québec, Axe Neurosciences, Québec, Canada.ORCID 0000-0003-2863-9626
Juan J P DeuderoBaylor College of Medicine, The Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, Texas, United States of America.
Amy L BrewsterBaylor College of Medicine, The Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, Texas, United States of America.
Anne E AndersonBaylor College of Medicine, The Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, Texas, United States of America.
Laura ZaldumbideUniversity Hospital of Cruces, Bilbao, Spain.
Lara GalbarriatuUniversity Hospital of Cruces, Bilbao, Spain.
Ainhoa MarinasUniversity Hospital of Cruces, Bilbao, Spain.
Maria dM VivancoCIC BioGUNE, Derio, Spain.
Carlos MatuteAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.
Mirjana Maletic-SavaticCentre de recherche du CHU de Québec, Axe Neurosciences, Québec, Canada.
Juan M EncinasAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.ORCID 0000-0002-0402-972X
Amanda SierraAchucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.ORCID 0000-0001-8415-096X
University of the Basque Country · ESCentre hospitalier universitaire de Québec · CABaylor College of Medicine · USHospital de Cruces · ESUniversité de Bordeaux · FRCIC bioGUNE · ESIkerbasque · ESUniversity of Southampton · GB

Funding

UNDERSTANDING FXTAS AMONG MALES WITH THE FMR1 PREMUTATIONP30HD024064 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI TOLIAS, KIMBERLY R · 1988 to 2013
$29.4M
The MAPK Cascade in EpilepsyR01NS039943 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ANDERSON, ANNE E · 2001 to 2011
$2.9M
Imaging Mass Spectrometry for metabolome mappingR01GM120033 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LIU, ZHANDONG, MALETIC-SAVATIC, MIRJANA · 2017 to 2021
$2.5M
Ion Channel Regulation of Excitability in Immature BrainR01NS049427 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ANDERSON, ANNE E · 2006 to 2010
$1.7M
Signaling pathway dysregulation in epilepsyR01NS081053 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ANDERSON, ANNE E · 2013 to 2016
$1.4M
Medical Research Council MR/K022687/1NICHD NIH HHS P30 HD024064NIGMS NIH HHS R01 GM120033NINDS NIH HHS R01 NS039943NINDS NIH HHS R01 NS049427NINDS NIH HHS R01 NS081053
6 · The paper itself

Abstract

Phagocytosis is essential to maintain tissue homeostasis in a large number of inflammatory and autoimmune diseases, but its role in the diseased brain is poorly explored. Recent findings suggest that in the adult hippocampal neurogenic niche, where the excess of newborn cells undergo apoptosis in physiological conditions, phagocytosis is efficiently executed by surveillant, ramified microglia. To test whether microglia are efficient phagocytes in the diseased brain as well, we confronted them with a series of apoptotic challenges and discovered a generalized response. When challenged with excitotoxicity in vitro (via the glutamate agonist NMDA) or inflammation in vivo (via systemic administration of bacterial lipopolysaccharides or by omega 3 fatty acid deficient diets), microglia resorted to different strategies to boost their phagocytic efficiency and compensate for the increased number of apoptotic cells, thus maintaining phagocytosis and apoptosis tightly coupled. Unexpectedly, this coupling was chronically lost in a mouse model of mesial temporal lobe epilepsy (MTLE) as well as in hippocampal tissue resected from individuals with MTLE, a major neurological disorder characterized by seizures, excitotoxicity, and inflammation. Importantly, the loss of phagocytosis/apoptosis coupling correlated with the expression of microglial proinflammatory, epileptogenic cytokines, suggesting its contribution to the pathophysiology of epilepsy. The phagocytic blockade resulted from reduced microglial surveillance and apoptotic cell recognition receptor expression and was not directly mediated by signaling through microglial glutamate receptors. Instead, it was related to the disruption of local ATP microgradients caused by the hyperactivity of the hippocampal network, at least in the acute phase of epilepsy. Finally, the uncoupling led to an accumulation of apoptotic newborn cells in the neurogenic niche that was due not to decreased survival but to delayed cell clearance after seizures. These results demonstrate that the efficiency of microglial phagocytosis critically affects the dynamics of apoptosis and urge to routinely assess the microglial phagocytic efficiency in neurodegenerative disorders.

Indexed as

Adenosine TriphosphateAdultAnimalsApoptosisCX3C Chemokine Receptor 1Epilepsy, Temporal LobeHumansKainic AcidLeukocyte Common AntigensMice, Inbred C57BLMice, TransgenicMicrogliaMonocytesNeuronsPhagocytosisReceptors, CCR2Adenosine TriphosphateCcr2 protein, mouseCX3C Chemokine Receptor 1Cx3cr1 protein, mouseKainic AcidLeukocyte Common AntigensPtprc protein, mouseReceptors, CCR2Receptors, Chemokine

Identifiers

PMID27228556
PMCPMC4881984
OpenAlexW2402129233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.